A simulation study to assess the potential benefits of MRI-based fetal weight estimation as a second-line test for suspected macrosomia

CONCLUSION: The superior accuracy of MRI-EFW over US-EFW for the diagnosis of macrosomia could result in lower rates of IOL without compromising the relative advantages of the intervention but fails to demonstrate a significant benefit to justify a replication of the original trial using MRI-EFW as a second-line test.PMID:38615575 | DOI:10.1016/j.ejogrb.2024.04.009
Source: Reproductive Biology - Category: Reproduction Medicine Authors: Source Type: research